Pivotal study of Modufolin in patients with colorectal cancer

Trial Profile

Pivotal study of Modufolin in patients with colorectal cancer

Planning
Phase of Trial: Phase II/III

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Folitixorin (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Isofol Medical
  • Most Recent Events

    • 04 Sep 2017 According to an Isofol Medical media release, this trial is scheduled to begin in the first quarter of 2018.
    • 24 Aug 2017 According to an Isofol Medical media release, this trial is scheduled to begin in 2018.
    • 05 Jul 2017 According to an Isofol Medical media release, the company plans to initiate this trial at the turn of the year 2017/2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top